Guess what? Google just announced TxGemma, a set of “open” AI models designed to accelerate drug discovery. Here’s what healthcare government agencies and health researchers should know: ?? Open AI for Health – TxGemma can analyze text, chemicals, molecules, and proteins, making drug research more accessible. ?? Faster, Smarter Drug Development – By predicting safety and efficacy, these models could help reduce time and costs in therapeutic research. ?? Challenges Remain – AI hasn’t been a magic bullet yet, as clinical trial failures show. Accuracy and real-world impact remain key concerns. ?? Big Pharma is Betting on AI – Despite hurdles, companies like Eli Lilly and Novartis are investing heavily in AI-driven drug design. ?? What’s Next? – With 460+ AI startups in drug discovery and $60B+ invested, government agencies should explore how AI-powered health innovation fits into future policies and programs. At Avenir Technology, we help government leaders harness AI for real-world impact. How do you see AI shaping the future of public health and drug discovery? Let’s discuss! ?? FDA The National Institutes of Health U.S. Department of Veterans Affairs #AI #DrugDiscovery #HealthTech #GovTech #AvenirTechnology
